Investment
Features
FeesSafety
Academy
More
Pluang+

Class action filed against Doximity over alleged misleading revenue claims and market share losses.

Market News
17 Sep 2026
PRNewsWire
View Source
Bearish
Class action filed against Doximity over alleged misleading revenue claims and market share losses.

A class action lawsuit has been filed against Doximity, Inc. for allegedly misleading investors about its revenue growth and market position between August 2024 and May 2026. The complaint claims Doximity overstated the impact of its Newsfeed product while losing market share to competitors with better pricing and engagement strategies. The stock price dropped significantly following cautious outlooks and lowered revenue guidance, prompting investor losses. Investors who bought Doximity stock during the class period may be eligible to join the lawsuit before the November 16, 2026 deadline.

Doximity, Inc. faces a class action lawsuit over alleged investor misinformation, providing context for readers tracking health sector stocks. For readers following the health sector, here is Pluang's market snapshot as of Sep 18, 2026 05:01 WIB: Of 91 priced health-sector US stocks tradable on Pluang, 60 rose and 31 fell today. Notable movers include AbCellera Biologics Inc (ABCL) at USD 12.74 with a 9.17% increase, Moderna, Inc. (MRNA) at USD 158.13 up 8.59%, and Illumina, Inc. (ILMN) at USD 246.99 rising 7.89%. Typical hold times range from 40 to 86 days, with varied Pluang order activity percentages.

More News

TIFF 2026 boosts Toronto spending by 12%, aiding small businesses and driving city-wide economic growth

TIFF 2026 boosts Toronto spending by 12%, aiding small businesses and driving city-wide economic growth

Visa Canada's data reveals that the Toronto International Film Festival (TIFF) 2026 increased visitor spending by 12% compared to 2025, with international visitors spending about 40% more than Canadian cardholders. The festival attracted visitors mai...

Market News
Bullish
1 hour ago
Aclarion broadens CLARITY trial criteria to speed patient enrollment, keeping trial timeline on track.

Aclarion broadens CLARITY trial criteria to speed patient enrollment, keeping trial timeline on track.

Aclarion, Inc. has updated the enrollment criteria for its CLARITY clinical trial to better reflect real-world chronic low back pain patients and accelerate patient recruitment. The revised criteria, approved at most active sites, expand the pool of ...

Market News
Bullish
2 hours ago
Zscaler CEO Jay Chaudhry sells 2,852 shares for $550,000

Zscaler CEO Jay Chaudhry sells 2,852 shares for $550,000

Zscaler CEO Jay Chaudhry has sold 2,852 shares of the company, generating $550,000 from the transaction. This sale could indicate personal financial planning or portfolio rebalancing by the CEO. Investors might watch for any further insider activity ...

Market News
Bearish
2 hours ago
Ascentis Independent Advisors adds $1B in assets with four new advisory teams from Raymond James.

Ascentis Independent Advisors adds $1B in assets with four new advisory teams from Raymond James.

Ascentis Independent Advisors has expanded by adding four advisory teams from Raymond James Financial Services, bringing over $1 billion in client assets. These teams, based in California and Colorado, chose Ascentis to access enhanced planning, inve...

Market News
Bullish
3 hours ago
Orbit International reports $8.2M bookings in Q3 2026, surpassing 2025 total bookings for its power group.

Orbit International reports $8.2M bookings in Q3 2026, surpassing 2025 total bookings for its power group.

Orbit International Corp. announced consolidated bookings of approximately $8.2 million for Q3 2026, with deliveries expected to complete by Q1 2028. The Orbit Power Group (OPG) contributed over $3.8 million, exceeding 2025 total bookings by 24.6%, d...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App